B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches

Por Shah, Nina, Chari, Ajai, Scott, Emma, Mezzi, Khalid, Usmani, Saad Z.
Publicado no Leukemia (2020)

Incidence and risk of hypertension in patients newly treated for multiple myeloma: a retrospective cohort study

Por Chari, Ajai, Mezzi, Khalid, Zhu, Shao, Werther, Winifred, Felici, Diana, Lyon, Alexander R.
Publicado no BMC Cancer (2016)

Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma

Por Landgren, Ola, Sonneveld, Pieter, Jakubowiak, Andrzej, Mohty, Mohamad, Iskander, Karim S., Mezzi, Khalid, Siegel, David S.
Publicado no Leukemia (2019)

Efficacy and Safety of Busulfan-Based Conditioning Regimens for Multiple Myeloma

Por Reece, Donna, Song, Kevin, LeBlanc, Richard, Mezzi, Khalid, Olujohungbe, Ade, White, Darrell, Zaman, Faraz, Belch, Andrew
Publicado em 2013

A real-world comparative analysis of carfilzomib and other systemic multiple myeloma chemotherapies in a US community oncology setting

Por Rifkin, Robert M., Medhekar, Rohan, Amirian, E. Susan, Aguilar, Kathleen M., Wilson, Thomas, Boyd, Marley, Mezzi, Khalid, Panjabi, Sumeet
Publicado no Ther Adv Hematol (2019)

Carfilzomib vs bortezomib in patients with multiple myeloma and renal failure: a subgroup analysis of ENDEAVOR

Por Dimopoulos, Meletios, Siegel, David, White, Darrell J., Boccia, Ralph, Iskander, Karim S., Yang, Zhao, Kimball, Amy S., Mezzi, Khalid, Ludwig, Heinz, Niesvizky, Ruben
Publicado no Blood (2019)

Targeting MCL-1 in Hematologic Malignancies: Rationale and Progress

Por Wei, Andrew H., Roberts, Andrew W., Spencer, Andrew, Rosenberg, Aaron Seth, Siegel, David, Walter, Roland B., Caenepeel, Sean, Hughes, Paul, McIver, Zach, Mezzi, Khalid, Morrow, Phuong Khanh, Stein, Anthony
Publicado no Blood Rev (2020)

Once‐weekly (70 mg/m(2)) vs twice‐weekly (56 mg/m(2)) dosing of carfilzomib in patients with relapsed or refractory multiple myeloma: A post hoc analysis of the ENDEAVOR, A.R.R.O.W...

Por Moreau, Philippe, Stewart, Keith A., Dimopoulos, Meletios, Siegel, David, Facon, Thierry, Berenson, James, Raje, Noopur, Berdeja, Jesus G., Orlowski, Robert Z., Yang, Hui, Ma, Haijun, Klippel, Zandra, Zahlten‐Kumeli, Anita, Mezzi, Khalid, Iskander, Karim, Mateos, Maria‐Victoria
Publicado no Cancer Med (2020)

Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma

Por Facon, Thierry, Niesvizky, Ruben, Mateos, Maria-Victoria, Siegel, David, Rosenbaum, Cara, Bringhen, Sara, Weisel, Katja, Ho, P. Joy, Ludwig, Heinz, Kumar, Shaji, Wang, Kenneth, Obreja, Mihaela, Yang, Zhao, Klippel, Zandra, Mezzi, Khalid, Goldrick, Amanda, Tekle, Christina, Dimopoulos, Meletios A.
Publicado no Blood Adv (2020)